Platelet‐Inspired Nanocells for Targeted Heart Repair After Ischemia/Reperfusion Injury
Teng Su,Ke Huang,Hong Ma,Hongxia Liang,Phuong‐Uyen Dinh,Justin Chen,Deliang Shen,Tyler A. Allen,Li Qiao,Zhenhua Li,Shiqi Hu,Jhon Cores,Brianna N. Frame,Ashlyn T. Young,Qi Yin,Jiandong Liu,Li Qian,Thomas G. Caranasos,Yevgeny Brudno,Frances S. Ligler,Ke Cheng
DOI: https://doi.org/10.1002/adfm.201803567
IF: 19
2018-11-13
Advanced Functional Materials
Abstract:Cardiovascular disease is the leading cause of mortality worldwide. While reperfusion therapy is vital for patient survival post-heart attack, it also causes further tissue injury, known as myocardial ischemia/reperfusion (I/R) injury in clinical practice. Exploring ways to attenuate I/R injury is of clinical interest for improving post-ischemic recovery. A platelet-inspired nanocell (PINC) that incorporates both prostaglandin E2 (PGE<sub>2</sub>)-modified platelet membrane and cardiac stromal cell-secreted factors to target the heart after I/R injury is introduced. By taking advantage of the natural infarct-homing ability of platelet membrane and the overexpression of PGE<sub>2</sub> receptors (EPs) in the pathological cardiac microenvironment after I/R injury, the PINCs can achieve targeted delivery of therapeutic payload to the injured heart. Furthermore, a synergistic treatment efficacy can be achieved by PINC, which combines the paracrine mechanism of cell therapy with the PGE<sub>2</sub>/EP receptor signaling that is involved in the repair and regeneration of multiple tissues. In a mouse model of myocardial I/R injury, intravenous injection of PINCs results in augmented cardiac function and mitigated heart remodeling, which is accompanied by the increase in cycling cardiomyocytes, activation of endogenous stem/progenitor cells, and promotion of angiogenesis. This approach represents a promising therapeutic delivery platform for treating I/R injury.
materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology